Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT C O LAUGHLIN

Allopathic & Osteopathic Physicians Radiology Radiation Oncology

NPI
1699841254
CMS profile
895389
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$1,834.09

  • Reported across 97 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$343.37

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $343.37 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $232.96 13
PY2019 $186.58 11
PY2020 $86.47 6
PY2021 $295.91 17
PY2022 $182.49 10
PY2023 $506.31 24
PY2024 $343.37 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agios Pharmaceuticals, Inc. $21.36 11/12/2024 Food and Beverage Undisputed 01/23/2026 1149643430 CMS
AstraZeneca Pharmaceuticals LP $33.44 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105521231 CMS
AstraZeneca Pharmaceuticals LP $16.16 10/29/2024 Food and Beverage Undisputed 01/23/2026 1105326348 CMS
AstraZeneca Pharmaceuticals LP $19.08 12/27/2024 Food and Beverage Undisputed 01/23/2026 1104465438 CMS
Aveo Pharmaceuticals, Inc. $13.99 05/23/2024 Food and Beverage Undisputed 01/23/2026 1143485341 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.11 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086160420 CMS
Blue Earth Diagnostics Limited $32.76 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147790690 CMS
EMD Serono, Inc. $19.15 08/19/2024 Food and Beverage Undisputed 01/23/2026 1120243665 CMS
EMD Serono, Inc. $24.44 09/12/2024 Food and Beverage Undisputed 01/23/2026 1120261866 CMS
Janssen Biotech, Inc. $21.03 12/05/2024 Food and Beverage Undisputed 01/23/2026 1078390220 CMS
Merck Sharp & Dohme LLC $17.27 06/04/2024 Food and Beverage Undisputed 01/23/2026 1141790420 CMS
Merck Sharp & Dohme LLC $16.06 08/06/2024 Food and Beverage Undisputed 01/23/2026 1141899454 CMS
Novartis Pharmaceuticals Corporation $21.46 01/30/2024 Food and Beverage Undisputed 01/23/2026 1087244941 CMS
Novartis Pharmaceuticals Corporation $21.97 08/13/2024 Food and Beverage Undisputed 01/23/2026 1087244975 CMS
Stemline Therapeutics Inc. $26.81 12/24/2024 Food and Beverage Undisputed 01/23/2026 1142963544 CMS
Telix Pharmaceuticals $25.28 10/09/2024 Food and Beverage Undisputed 01/23/2026 1081984512 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.